Skip to main content
Log in

Fluconazole in the management of fungal urinary tract infections

Einsatz von Fluconazol bei durch Hefen verursachten Harnwegsinfektionen

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Summary

The presence ofCandida in the urine is not considered normal but does not necessarily indicate urinary tract infection. On the other hand, yeasts in urine cultures might be the first symptom of systemic fungal infections. Despite the difficulties that exist, establishment of an accurate diagnosis is important especially in high risk patients because ascending infections may lead to disseminated disease. Amphotericin B bladder irrigation is a common mode of therapy for fungal urinary tract infection, although no specific guidelines exist as to the use of the procedure. The pharmacokinetic parameters posessed by the triazole antifungal agent fluconazole make it a candidate for treating fungal urinary tract infections. Five case reports and 99 patients reported in several small studies were reviewed. As evident from these reports, fluconazole appears to be of value in the treatment of both uncomplicated and complicated fungal urinary tract infections.

Zusammenfassung

ObwohlCandida für gewöhnlich nicht im Urin vorkommt, läßt der Nachweis nicht sicher auf eine Harnwegsinfektion schließen. Andererseits kann der Nachweis von Hefen im Urin das erste Symptom einer systemischen Mykose sein. Trotz der bestehenden Probleme ist eine akkurate Diagnose, insbesondere bei Risikopatienten, von besonderer Bedeutung, da aszendierende Infektionen zur systemischen Erkrankung führen können. Amphotericin-B-Blasenspülung ist eine gebräuchliche Therapieform bei durch Pilzen verursachten Harnwegsinfektionen, obwohl keine spezifischen Richtlinien für diese Anwendung bestehen. Fluconazol erscheint aufgrund seiner Pharmakokinetik ideal für den Einsatz bei Harnwegsinfektionen. Die Ergebnisse von 5 Fallberichten und 99 Patienten aus verschiedenen, kleineren Studien, sind in diesem Review zusammengefaßt. Anhand der Ergebnisse dieser Studien erscheint der Einsatz von Fluconazol bei unkomplizierten und kompliziertenCandida-Harnwegsinfektionen gerechtfertigt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schaberg, D. R., Cluver, D. H., Gaynes, R. P. Major trends in the microbial etiology of nosocomial infections. Am. J. Med. 31 (Suppl. 3B) (1991) 72–75.

    Google Scholar 

  2. Weber, D. J., Rutala, W. A., Samsa, G. P., Wilson, M. B., Hoffmann, K. K. Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989. Am. J. Infect. Control 20 (1992) 192–197.

    Google Scholar 

  3. Johnson, J. R., Roberts, P. L., Olsen, R. J., Moyer, K. A., Stamm, W. E. Prevention of catheter-associated urinary tract infections with a silveroxide-coated urinary catheter: clinical and microbiological correlates. J. Infect. Dis. 162 (1990) 1145–1150.

    Google Scholar 

  4. Wise, G. J. Amphotericin B in urological practice. J. Urol. 144 (1990) 215–223.

    Google Scholar 

  5. Frye, K. R., Donovan, J. M., Drach, G. W. Torulopsis glabrata urinary infection: a review. J. Urol. 139 (1988) 1245–1249.

    Google Scholar 

  6. Baker, J. G., Nadler, H. L., Forgacs, P., Kurtz, S. R. Candida lusitaniae: a new opportunistic pathogen in the urinary tract. Diag. Microbiol. Infect. Dis. 2 (1984) 145–149.

    Google Scholar 

  7. Motola, J. A., Badlani, G. H., Lee, W. J. Renal fungal infections. Infect. Med. 9 (1992) 30–36.

    Google Scholar 

  8. Gubbins, P. O., Piscitelli, S. C., Danziger, L. H. Candida urinary tract infections: A comprehensive review of their diagnosis and management. Pharmacotherapy 13 (1993) 110–127.

    Google Scholar 

  9. Rubin, R. H., Shapiro, E. D., Andriole, V. T., Davis, R. J., Stamm, W. E. Evaluation of new anti-infective drugs for the treatment of urinary tract infections. Clin. Infect. Dis 15 (Suppl. 1) (1992) S216-S227.

    Google Scholar 

  10. Wong-Beringer, A., Jacobs, R. A., Guglielmo, B. J. Treatment of funguria. JAMA 267 (1992) 2780–2785.

    Google Scholar 

  11. Fisher, J. F., Chew, W. H., Shadomy, S., Duma, R. J., Mayhal, C. G., House, W. C. Urinary tract infections due toCandida albicans. Rev. Infect. Dis. 4 (1982) 1107–1118.

    Google Scholar 

  12. Edwards, J. E. Candida species. In:Mandell, G. L., Douglas, R. G., Bennett, J. E. (eds.): Principles and practice of infectious diseases. 3rd ed., Churchill Livingstone, New York, NY 1990, p. 1943.

    Google Scholar 

  13. Sanford, J. P. The enigma of candiduria: evolution of bladder irrigation with amphotericin B for management — from anecdote to dogma and a lesson from Machiavelli. Clin. Infect. Dis. 16 (1993) 145–147.

    Google Scholar 

  14. Brammer, K. W., Farrow, P. R., Faulkner, J. K. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12 (Suppl. 3) (1990) S318-S326.

    Google Scholar 

  15. Milatovic, D., Voss, A. Efficacy of fluconazole in the treatment of systemic fungal infections. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 395–402.

    Google Scholar 

  16. Robinson, P. A., Knirsch, A. K., Joseph, J. A. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. Rev. Infect. Dis. 12 (Suppl. 3) (1990) S348–363.

    Google Scholar 

  17. Tacker, J. R. Successful use of fluconazole for treatment of urinary tract fungal infections. J. Urol. 148 (1992) 1917–1918.

    Google Scholar 

  18. Dave, J., Hickey, M. M., Wilkins, E. G. L. Fluconazole in renal candidosis. Lancet i (1989) 163–164.

    Google Scholar 

  19. Corbella, X., Carratala, J., Castells, M., Berlanga, B. Fluconazole treatment inTorulopsis glabrata upper urinary tract infection causing ureteral obstruction. J. Urol. 146 (1992) 1116–1117.

    Google Scholar 

  20. Bergman, K. A., Meis, J. F., Horrevorts, A. M., Monnens, L. Acute renal failure in a neonate due to pelviureteric candidal bezoars successfully treated with long-term systemic fluconazole. Acta Paediatr. 81 (1992) 709–711.

    Google Scholar 

  21. Nito, H. Clinical efficacy of fluconazole in urinary tract fungal infections. Jpn. J. Antibiot. 42 (1989) 171–178.

    Google Scholar 

  22. McGuire, L. M., Wise, G. J.: Fluconazole treatment of urinary fungal infections. J. Urol. 147 (1992) 231A.

  23. Phillips, R. J. M., Morrissey, E., Watson, S. A., Walsh, R., Jevons, S. The antifungal drug fluconazole: a review of 154 cases of opportunistic fungal infection. J. Drug. Develop. 4 (1991) 31–38.

    Google Scholar 

  24. Wang, J. H., Liu, Y. C., Cheng, D. L., Yen, M. Y., Chen, Y. S., Wang, Y. H. Comparative study of fluconazole and amphotericin B in the treatment of catheter-related candiduria. JAMA 9 (Suppl.) (1993) 32–33.

    Google Scholar 

  25. Castiglia, M., Fisher, M.: Use of fluconazole in the treatment of candiduria: a retrospective view. Proceedings of the 93rd General Meeting of the American Society for Microbiology, Atlanta, 1993, abstr. F-49.

  26. Fan-Havard, P., Oh, J., O'Donovan, C. A., Smith, S. M., Eng, R. H. K., Bamberger, M. H.: Amphotericin B bladder irrigation vs fluconazole in the treatment of candidal cystitis. Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, 1992, abstr. 631.

  27. Ralph, E. D., Barber, K. R., Grant, C. W. M. Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused byCandida albicans. Am. J. Nephrol. 11 (1991) 118–122.

    Google Scholar 

  28. Fisher, J. F., Hicks, B. C., Dipiro, J. T., Venable, J., Fincher, R. M. E. Efficacy of a single intravenous dose of amphotericin B in urinary tract infections caused byCandida. J. Infect. Dis. 156 (1987) 685–687.

    Google Scholar 

  29. Ikemoto, H. A clinical study of fluconazole for the treatment of deep mycoses. Diag. Microbiol. Infect. Dis. 12 (Suppl. 4) (1989) 239–247.

    Google Scholar 

  30. Hamory, B. H., Wenzel, R. P. Hospital-associated candiduria: predisposing factors and review of the literature. J. Urol. 120 (1977) 444–448.

    Google Scholar 

  31. Cunha, B. A., Pugliese, A., Klein, N. C. Fungal and parasitic UTIs. Infect. Med. 9 (1992) 10–16.

    Google Scholar 

  32. Hay, R. J. Antifungal therapy and the new azole compounds. J. Antimicrob. Chemother. 28 (Suppl. A) (1991) 35–46.

    Google Scholar 

  33. Bodey, G. P., Milatovic, D., Braveny, I. The antimicrobial pocket book. Vieweg, Braunschweig/Wiesbaden 1991.

    Google Scholar 

  34. Butler, C. D. Drugs for opportunistic fungal infections. Drug Newslet. 10 (1991) 14.

    Google Scholar 

  35. Hsu, C. C. S., Ukleja, B. Clearance of Candida colonizing the urinary bladder by a two-day amphotericin B irrigation. Infection 18 (1990) 280–282.

    Google Scholar 

  36. Johnson, J. R. Should all catheterized patients with candiduria be treated? Clin. Infect. Dis. 17 (1993) 814.

    Google Scholar 

  37. Wise, G. J., Kozinn, P. J., Goldberg, P. Amphotericin B as urologic irrigant in the management of noninvasive candiduria. J. Urol. 128 (1982) 82–84.

    Google Scholar 

  38. Sandford, J. P. Bladder irrigation with amphotericin B for treatment of patients with candiduria. Reply. Clin. Infect. Dis. 17 (1993) 813.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voss, A., Meis, J.F.G.M. & Hoogkamp-Korstanje, J.A.A. Fluconazole in the management of fungal urinary tract infections. Infection 22, 247–251 (1994). https://doi.org/10.1007/BF01739908

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01739908

Keywords

Navigation